Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

INTRODUCTION: Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative processes, the early differentiation of the under...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eimeren, Thilo, Antonini, Angelo, Berg, Daniela, Bohnen, Nico, Ceravolo, Roberto, Drzezga, Alexander, Höglinger, Günter U., Higuchi, Makoto, Lehericy, Stephane, Lewis, Simon, Monchi, Oury, Nestor, Peter, Ondrus, Matej, Pavese, Nicola, Peralta, María Cecilia, Piccini, Paola, Pineda-Pardo, José Ángel, Rektorová, Irena, Rodríguez-Oroz, María, Rominger, Axel, Seppi, Klaus, Stoessl, A. Jon, Tessitore, Alessandro, Thobois, Stephane, Kaasinen, Valtteri, Wenning, Gregor, Siebner, Hartwig R., Strafella, Antonio P., Rowe, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Special Section: Brain Imaging Working Group Summaries for the European Joint Programme for Neurodegenerative Disease Research (JPND). (Guest Editors: Jorge Jovicich & Giovanni B. Frisoni)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446052/
https://www.ncbi.nlm.nih.gov/pubmed/30984816
http://dx.doi.org/10.1016/j.dadm.2019.01.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446052/
https://www.ncbi.nlm.nih.gov/pubmed/30984816
http://dx.doi.org/10.1016/j.dadm.2019.01.011

Ejemplares similares